KPRX (Kiora Pharmaceuticals, Inc.) חוב לטווח קצר להון

Kiora Pharmaceuticals relies on an extensive cold-chain supply network to protect its medications while outsourcing formula development and testing to external contractors, allowing the company to remain a research hub. This price chart demonstrates the 0.01 indicator. Kiora Pharmaceuticals maintains an impeccable reputation among physicians due to its transparent development of therapies for hereditary retinal pathologies.

This ratio compares the volume of liabilities with a maturity of over one year to equity, determining the extent to which the financing structure depends on borrowed funds. For Kiora Pharmaceuticals (KPRX), which invests in ophthalmology development and international trials, this short-term financial leverage indicator reflects the balance between debt load and financial stability while scaling innovative products.